European Green Transition Plc EGT
LSE · United Kingdom · Utilities
GBp 11.500.00 (0.00%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
European Green Transition PLC (AIM:EGT) CFO Jack Kelly spoke with Proactive's Stephen Gunnion about the renewal of a five-year operations and maintenance contract covering 94 wind turbines with Drax Group, and what the agreement means for the company's wind services business and wider growth strategy. Kelly described the renewal as "great news," highlighting the importance of extending the relationship with a long-term customer for a further five years, providing revenue and financial visibility across a large proportion of the company's turbines through to 2031. The contract covers a technica
Pan African Resources PLC (LSE:PAF, OTCQX:PAFRY, JSE:PAN) has reported a record year, with gold production up almost 40%. Earnings nearly tripled, and it's proposing a record final dividend. European Green Transition PLC (AIM:EGT) says its first half was a "transformational period" after completing its Wind Services acquisition. Its repowering orderbook now represents a potential £126 million opportunity. HeLIX Exploration PLC (AIM:HEX, OTCQB:HHEXF) has spudded the Ollie #1 at its Rudyard helium field in Montana. It's targeting the same formations that have already produced commercial-grade he
Ilika (AIM:IKA) says it's now a revenue-generating business, with initial royalties from its Stereax miniature solid-state batteries expected in its 2027 financial year. Releasing its 2026 results, the company said its larger Goliath battery is also attracting interest from defence and e-bike markets, including a collaboration with Brompton Bicycle. Allergy Therapeutics (AIM:AGY) says revenue growth accelerated in its second half, with full-year revenue up 9% to £59.9 million. Double-digit growth is expected next year as Grassmuno enters its first full peak treatment season. Ecora Royalties (L
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.